DS
ACHV icon

David Shaw’s Achieve Life Sciences ACHV Stock Holding History

David Shaw’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6
Closed -$9K – 3319
2016
Q1 		$9K Hold
6
– – ﹤0.01% 3360
2015
Q4 		$16K Buy
+6
New +$25.4K ﹤0.01% 3747
2015
Q3 		– Sell
-17
Closed -$85K – 3696
2015
Q2 		$85K Sell
17
-5
-23% -$24.8K ﹤0.01% 3662
2015
Q1 		$103K Sell
22
-43
-66% -$211K ﹤0.01% 3524
2014
Q4 		$325K Buy
65
+33
+103% +$161K ﹤0.01% 3610
2014
Q3 		$188K Buy
32
+10
+45% +$69.5K ﹤0.01% 3910
2014
Q2 		$180K Buy
+22
New +$270K ﹤0.01% 4012
2013
Q3 		– Sell
-5
Closed -$98K – 4254
2013
Q2 		$98K Buy
+5
New +$112K ﹤0.01% 3879

Other funds holding ACHV

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

David Shaw's ACHV Position: Q2 2016 in Review

David Shaw sold out of Achieve Life Sciences (ACHV) in Q2 2016, closing a stake of 6 shares — an estimated $9K sold.

David Shaw first reported a position in ACHV in Q2 2013 and held it in 8 quarters. The position peaked at $325K in Q4 2014. 34 funds tracked by Wall St. Rank hold ACHV as of Q2 2016.

  • David Shaw reported no remaining Achieve Life Sciences position as of Q2 2016 after selling out during the quarter.
  • David Shaw sold 6 Achieve Life Sciences shares in Q2 2016, an estimated $9K.
  • David Shaw first reported a position in Achieve Life Sciences in Q2 2013 and held it in 8 quarters.
  • David Shaw's Achieve Life Sciences position peaked at $325K in Q4 2014.
  • 34 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2016.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.